In an expansion of the company’s “An Accord for a Healthier World” program, which is aimed at increasing access to innovative treatments in some of the world’s poorest countries, Pfizer said it will now offer a total of 500 products.
Maternal vaccination reduced rates of severe medically attended lower respiratory tract illness due to RSV by 81.8% across the first three months of life.
U.S. drug company Pfizer will allow its experimental Covid-19 treatment pill to be made and sold in 95 developing nations. The deal could make the treatment available to 53% of the world’s population.
The first 200 million doses will be distributed this year, with the subsequent 300 million shared in the first half of next year.
Over 41,000 people had completed the vaccination protocol. Out of the 170 positive COVID cases detected in the trial only eight were observed in the active vaccine group.
The US Food and Drug Administration (FDA) set a minimum effectiveness bar for COVID-19 vaccines at 50% for drugs seeking approval. This is the first COVID-19 candidate vaccine to produce data exceeding that mark.
